86.22.Z - Specialist medical practice activities
47.78.Z - Other retail sale of new goods in specialised stores
72.19.Z - Other research and experimental development on natural sciences and engineering
85.59.B - Other out-of-school forms of education, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 5,7 | 35,3 | 72,5 | 105,4 |
EBITDA | -175,3 | |||
Short time liabilities | 69,9 | 120,9 | 72,9 | |
Income tax | 0 | |||
Equity capital | 3,4 | 36 | 102 | 183 |
Operating profit (EBIT) | 35,3 | 72,5 | 105,4 | |
Assets | 0 | 105,9 | 222,8 | 110,3 |
Net profit (loss) | 5,7 | 32,6 | 65,9 | 102,2 |
Cash | 45,9 | 130,1 | 183,2 | |
Liabilities and provisions for liabilities | 65,8 | 69,9 | 120,9 | 72,9 |
Net income from sale | 273,9 | 381,5 | 39,3 | |
Working assets | 69,2 | 45,9 | 186,8 | 306,7 |
Basic operational activity income | 312 | |||
Depreciation | -100 | |||
% | % | % | p.p. | |
Profitability of capital | 167,7 | -31,3 | ||
Equity capital to total assets | 34 | 45,8 | 11,8 | |
Gross profit margin | 1,8 | 12,9 | 19 | 6,1 |
EBITDA Margin | -4,6 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 93 | 116 | 23 | |
Current financial liquidity indicator | 0.6570863723754883 | 1.5456311702728271 | 0,8 | |
Net dept to EBITDA | 0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane